Telemonitoring System for Patients with Diabetes: a randomised controlled trial.
Not Applicable
- Conditions
- diabettes, impaired glucose tolerance
- Registration Number
- JPRN-UMIN000011204
- Lead Sponsor
- Kanazawa University Hospital,Department of Endocrinology and Metabolism
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with malignant hypertension or secondary hypertension 2) Diabetic patients requiring medical treatment 3) Pregnant and probably pregnant patients 4) patients with abnormal serum creatinin value 5) Patients with severe hepatic dysfunction 6) Patients who had myocardial infarction or apoplexy within 3 months before the satrt of the study or who are treated. 7) Patients with severe allergy or with treatment by steroid 8) Patients with pancreatitis or pasthistory of pancreatitis 9) Patients with malignacy 10) other patients judged as being inappropriate for the subjects of the study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method following items before and 3 months after the introduction of home telemonitoring system 1 plasma glucose level, HbA1C 2 Urine alubumin excretion 3 Lipid levels 4 Blood pressure 5 Body weight, Body Mass Index 6 Diabetic complication 7 newly required medicine for diabetes, blood pressure, or dyslipidemia
- Secondary Outcome Measures
Name Time Method